CRUK Convergence Science Centre

#Cancer evolves like an ecosystem🌳- can #maths & #AI help us treat it smarter?

@stroblmar.bsky.social, an Eric & Wendy Schmidt AI in Science Fellow at @imperial-ix.bsky.social and @icr.ac.uk, is exploring how evolutionary modelling could personalise treatment and delay resistance

👉 bit.ly/3KtLdy0

📺TONIGHT: Don't miss 'Cancer Detectives: Finding the Cures' at 9pm on Channel 4.

Hear from Professor Juanita Lopez and the pioneering 5G trial – the first adaptive clinical trial platform for brain cancer patients.

Learn more here ⬇️
www.icr.ac.uk/about-us/icr...

Accelerating Pancreatic Cancer Test Adoption: A Multi-Stakeholder Call to Action A short film highlighting the challenges of translating new pancreatic cancer tests into GP settings—featuring clinicians, scientists, and patients calling on the NHS and stakeholders for faster adoption.

💜Nov is #PancreaticCancerAwarenessMonth. #PancreaticCancer remains hard to detect & treat, with slow improvements in survival.🙏Thank you to those who supported this video, highlighting that progress relies on multistakeholder action to accelerate the adoption of early-detection tests. bit.ly/4rGiln1

Students dove into:
🔬 Translational pathways & gap-spotting (CSC Catalyst Team)
🧪 Clinical trial design ( @icr-ctsu.bsky.social)
🤝 #PPIE essentials
🚀 Spin-out & #entrepreneurship (FLASH, Cardiovolt .ai)
💡 #IP, commercialisation & translation support ( @imperialenterprise.bsky.social & @icr.ac.uk)

#BenchToBedside: Our Centre-funded students gathered last week to explore how discoveries become real clinical impact. Sessions covered translational science, #ClinicalTrials, #PPIE, #Entrepreneurship, and taking innovations into practice.
Thanks to our brilliant speakers for sharing their expertise

🎤 Dr Wenjia Bai (@imperialcollegeldn.bsky.social)
🫀 Look into your heart: From image to mesh

🎤 Dr Matthew Blackledge (@icr.ac.uk)
📷 Combining Bayesian Methods and AI for Improved Heterogeneous Imaging Biomarker Estimation in Whole-Body MRI of Advanced #ProstateCancer

#ConvergingOnCancer Seminar: #AI in medical imaging 🤖 📸

Find out how #ConvergenceScience can be used in #CancerResearch, chaired by Prof Paul French, Department of Physics at Imperial College London.

🗓️ Thursday 4th December, 3-4pm
✍ bit.ly/4pskalg

🤝 Researchers and the community came together for a community partner-led event that sparked new collaborations, fresh ideas and renewed energy for meaningful patient and public #involvement in #CancerResearch.
Read the full article: bit.ly/47QrJML
#PPIE #Cancer

🌟 Early Career Clinicians: Apply for our Clinical Research Training Fellowship with @icr.ac.uk and @imperialcollegeldn.bsky.social to build your #research skills and accelerate your #academic career.

👉 bit.ly/3LNTxc1
🗓 Deadline: 11 Jan 2026

#ConvergenceScience #CRF #Cancer #CancerResearch

❗One week left to apply for our intercalated #PhD (iPhD) ⌛

If you're a medical student interested in becoming a clinician-scientist, check out our PhD projects for 2026. 👇

📣Call open for our 2026 Development Fund

Up to £80K for 12 months to support bold, cross-disciplinary #CancerResearch that bridges the life, clinical, #engineering & #PhysicalSciences across @imperialcollegeldn.bsky.social & @icr.ac.uk

➡️ bit.ly/4qVGLID

#FundingOpportunity #ConvergenceScience

🗣️ Joshua Killilea, iPhD
🧠Electroactive Drug Delivery for Local #Glioblastoma Treatment

🗣️Nick Waldron, CRF PhD
🤔Decoding the RAF-MEK-ERK-RSK Pathway in #ProstateCancer: From Molecular Mechanisms to Clinical Opportunities

@imperialcollegeldn.bsky.social @icr.ac.uk

🌟Meet the next generation of #ConvergenceScience researchers at our Future Leaders #seminar! Centre #PhD students present their research and share how they navigate different disciplines & shape their scientific paths.

📅Wed 12 November, 3-4pm
Hosted by: @udaibanerji.bsky.social
🔗 bit.ly/4oP1r2Z

Looking for a #PhD in #CancerResearch and #DataScience? 🤔

Applications are now open for our #ConvergenceScience Non-Clinical Data Science PhD programme, in partnership with StatML.

Sign up to 1 of 3 Q+A sessions or check out our website for more information 👉 bit.ly/43bid48

We’re thrilled to welcome our new CSC Cohort!🚀

Huge thanks to Professors McNeish, Isacke & Behrens for their insights, and to Shahrzad Forouzanfar, Bowen Su & Diana David for introducing our facilities. Here’s to a year of discovery, growth & achievement!💪

#PhD #ConvergenceScience #CancerResearch

🎙️Holger Auner (Lausanne University Hospital)
🎯 Targeting proteostasis and translation control in hematopoietic and solid cancers

🎙️Morten Frodin (BRIC, Copenhagen)
🧬CRISPR-Select: A fast, accurate and versatile functional-genetic assay to dissect the roles genes and variants/mutations in cancer

🌍 #ConvergingOnCancer: International Online Seminar

An #AcademicSeminar for our partners across #Europe and #Singapore to demonstrate how #ConvergenceScience is used to answer #Cancer related questions.

🗓 Thursday 6th Nov 2025
🕙 10–11am GMT | 11–12 CET | 6–7pm SGT
🔗http://bit.ly/4qmRxqX

📢 We're #hiring a #Health Economist to be part of our #Cancer Technology Catalyst Team to expedite the journey of promising cancer technologies from concept to clinical impact.

Find out more and share with your networks 👇
jobs.icr.ac.uk/vacancies/13...

#ConvergenceScience #Economics

Over half of #cancers show MYC deregulation - long seen as “undruggable.” #Research from @imperialcollegeldn.bsky.social & @icr.ac.uk, with #PhD student James Zhang, finds MYC cancers may be vulnerable to NMT inhibitors.

Learn more 👉http://bit.ly/4on0EGm

#ConvergenceScience #CancerResearch

⚡Can light could be used to manipulate tumour-associated bacteria?🦠Find out how Prof Anguraj Sadanandam, Dr Jang Ah Kim and @jameskinross.bsky.social from @icr.ac.uk and @imperialsandc.bsky.social are investigating how this could make #immunotherapies safer and more effective.
#ConvergenceScience

🤖 Find out how nanotechnology is being used to both prevent the spread and deliver targeted treatment for advanced #ProstateCancer – led by Dr Robert Kypta and a multi-disciplinary team of scientists across Imperial: @imperialsandc.bsky.social @impengineering.bsky.social 👇
#ConvergenceScience

@cancerresearchuk.org
@imperialmed.bsky.social
@icr.ac.uk

🩺 Are you a #MedStudent doing an iBSc? We're looking for future clinician-scientists to join our intercalated #PhD ( #iPhD) programme in 2026.

Explore projects & apply by 20 Nov 👉 bit.ly/48YA5Tp

Please share with your networks!

#CancerResearch #ConvergenceScience #CRUKFunded

🔎 Bringing together expertise in #bioengineering, optical #physics and #oncology to enhance earlier detection of #cancer. Find out more about how this #research led by @pantazislab.bsky.social and @udaibanerji.bsky.social is shaping the future of cancer diagnosis. 👇

Early stages of #metastasis are poorly understood despite causing 90% of cancer deaths. A new project led by Prof Darryl Overby and Prof @vickysanzmoreno.bsky.social is looking to develop tools to study #cancer spread in unprecedented detail while reducing the need for animals in research.🐁👇

🩸Find out more about how a team of scientists, led by Dr
Sylvain Ladame at @impengineering.bsky.social and Prof Nick Turner at @icr.ac.uk are developing better blood tests to predict treatment outcomes in #cancer patients. 👇

#ConvergenceScience #Oncology #CancerResearch
@cancerresearchuk.org

Congratulations to our 2025 Development Fund awardees! 🎉

From new detection tools to targeted nanotech therapies, these seed funded projects explore bold ideas to improve cancer diagnosis & treatment.
👉 bit.ly/4gV38tf

@icr.ac.uk @imperialcollegeldn.bsky.social @imperialsandc.bsky.social

A study led by our Scientific Director Prof Axel Behrens, found that blocking protein SPP1 can boost survival & stop the spread of #PancreaticCancer in mice. A breakthrough that could pave the way for new targeted treatments.
👉 bit.ly/4gTvG6q
@icr.ac.uk @imperialsandc.bsky.social @nature.com

🎤Prof @trevorgraham.bsky.social (@cec-icr.bsky.social)
Tracking cancer evolution at clinical scale with fluctuating methylation

🎤Dr Rachael Barry (Imperial)
Targeting Hydrolytic Enzymes in Colorectal Cancer

Chair: Prof Anguraj Sadanandam, ICR Systems & Precision Cancer Medicine Group Leader

Is it possible to predict the trajectory of cancer and prevent progression? 🤔 Find out how #ConvergenceScience can answer this at our upcoming #ConvergingOnCancer seminar for colleagues across the @icr.ac.uk and @imperialcollegeldn.bsky.social

📅 Thurs 2nd Oct 2025
⌚ 3-4pm BST
✍️ bit.ly/4pIObhS